Emerging research suggest Retatrutide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could represent a promising development for obesity management . https://maximusbookmarks.com/story21503842/a-retatru-tide-compound-the-advancement-in-weight-management